Tumor Suppressor Mutations and Growth Factor Signaling in the Pathogenesis of NF1‐Associated Peripheral Nerve Sheath Tumors. I. The Role of Tumor Suppressor Mutations

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNEN/63.11.1115PMID 15581179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Notch and Schwann cell transformation

  2004cited by this paper
• Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin

  2004cited by this paper
• Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells

  2004influential reference
• Comparative Pathology of Nerve Sheath Tumors in Mouse Models and Humans

  2004cited by this paper
• Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.

  2003cited by this paper
• Evidence for involvement of a tumor suppressor gene on 1p in malignant peripheral nerve sheath tumors.

  2003cited by this paper
• p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin*

  2002cited by this paper
• Pathogenesis of hereditary tumors: beyond the “two‐hit” hypothesis

  2002cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Neurofibromin regulates G protein–stimulated adenylyl cyclase activity

  2002cited by this paper
• Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors

  2002cited by this paper
• Neurofibroma and schwannoma

  2002cited by this paper
• International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

  2002cited by this paper
• Plexiform neurofibromas in NF1: toward biologic-based therapy.

  2002cited by this paper
• The neurofibromatoses: when less is more.

  2001cited by this paper
• Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.

  2001cited by this paper
• Neurofibromin, a tumor suppressor in the nervous system.

  2001cited by this paper
• Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization.

  2001cited by this paper
• Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath Tumors

  2001cited by this paper
• NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.

  2001cited by this paper
• Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.

  2001cited by this paper
• Signal transduction by the JNK group of MAP kinases.

  2000cited by this paper
• Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a Subpopulation of Neurofibroma Schwann Cells but Not Fibroblasts*

  2000cited by this paper
• Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors

  2000cited by this paper
• Regulatory Proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3*

  2000cited by this paper
• Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease.

  2000cited by this paper
• Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group

  2000cited by this paper
• Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

  2000cited by this paper
• Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.

  2000cited by this paper
• Neurofibromatosis type 1 I. General overview

  2000cited by this paper
• Neurofibromatosis type 1.

  2000cited by this paper
• Computer‐assisted cytogenetic analysis of 51 malignant peripheral‐nerve‐sheath tumors: Sporadic Vs. neurofibromatosis‐type‐1‐associated malignant schwannomas

  1999cited by this paper
• Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects.

  1999cited by this paper
• Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells.

  1999cited by this paper
• Loss of NF1 allele in schwann cells but not in fibroblasts derived from an NF1‐associated neurofibroma

  1999cited by this paper
• Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant

  1999cited by this paper
• Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

  1999cited by this paper
• Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: Studies of CDKN2A and other genes of the pRB pathway

  1999cited by this paper
• Mouse models of tumor development in neurofibromatosis type 1.

  1999cited by this paper
• R-Ras Signals through Specific Integrin α Cytoplasmic Domains to Promote Migration and Invasion of Breast Epithelial Cells

  1999cited by this paper
• Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.

  1999cited by this paper
• Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

  1999cited by this paper
• Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.

  1999cited by this paper
• Mouse tumor model for neurofibromatosis type 1.

  1999cited by this paper
• Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart.

  1998cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2

  1998cited by this paper
• A role for Pak protein kinases in Schwann cell transformation.

  1998influential reference
• Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

  1997cited by this paper
• Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis.

  1996cited by this paper
• Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21–q22 in soft tissue sarcomas

  1995cited by this paper
• Genetic and Epigenetic Mechanisms in the Pathogenesis of Neurofibromatosis Type 1

  1995cited by this paper
• Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours

  1995cited by this paper
• Cytogenetic findings in malignant peripheral nerve sheath tumors

  1995cited by this paper
• Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression

  1995cited by this paper
• Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

  1994cited by this paper
• Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

  1994cited by this paper
• TP53 mutations are frequent in malignant NFI tumors

  1994cited by this paper
• Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis

  1993cited by this paper
• Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

  1992cited by this paper
• Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

  1992cited by this paper
• Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

  1990cited by this paper
• Angiogenic and invasive properties of neurofibroma Schwann cells

  1990cited by this paper
• Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

  1986cited by this paper

• Protein Kinase C-alpha Gene Fusions in Dendritic Cell Neurofibroma: Distinction From Conventional Neurofibroma.

  2025cites this paper
• Role of nerves in neurofibromatosis type 1-related nervous system tumors.

  2022cites this paper
• Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration

  2022cites this paper
• NF1 Gene

  2018cites this paper
• Identification et implication des gènes DMD et RCBTB1 dans la progression tumorale des sarcomes à génétique complexe

  2017cites this paper
• The Understanding of Genodermatores Based on the Biochemical Pathogenesis (2)

  2014cites this paper
• Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

  2013cites this paper
• Neurogenic Tumors of Soft Tissue

  2012cites this paper
• Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms

  2012cites this paper
• Morphological and Immunohistochemical Characterization of Sarcomatous Tumors in Wild-Type and Genetically Engineered Mice

  2012cites this paper
• Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists

  2011cites this paper
• Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.

  2011cites this paper
• Soft tissue sarcomas with complex genomic profiles

  2010cites this paper
• Pathology and Classification of Tumors of the Nervous System

  2010cites this paper
• A Genetic Screen for Anchorage-Independent Proliferation in Mammalian Cells Identifies a Membrane-Bound Neuregulin

  2010cites this paper
• Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2

  2009cites this paper
• Neuregulin‐1β and neuregulin‐1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells

  2009cites this paper
• How does the Schwann cell lineage form tumors in NF1?

  2008cites this paper
• [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].

  2006cites this paper
• Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.

  2006cites this paper
• Neuregulin Growth Factors and Their ErbB Receptors Form a Potential Signaling Network for Schwannoma Tumorigenesis

  2006cites this paper
• Tumor Suppressor Mutations and Growth Factor Signaling in the Pathogenesis of NF1-Associated Peripheral Nerve Sheath Tumors: II. The Role of Dysregulated Growth Factor Signaling

  2005cites this paper
• Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors

  2005cites this paper
• A molecular map of mesenchymal tumors

  2005cites this paper
• Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1.

  2004cites this paper